Literature DB >> 11284525

Intravenous immunoglobulin therapy for Stevens-Johnson syndrome.

A S Brett1, D Philips, A W Lynn.   

Abstract

Stevens-Johnson syndrome (SJS) is an acute mucocutaneous disorder that can be associated with considerable morbidity. Several previous reports, all involving either adults with acquired immunodeficiency syndrome or children, suggest that intravenous immunoglobulin may be an effective treatment for SJS. We report a case of SJS in an immunocompetent adult whose condition improved dramatically after therapy with intravenous immunoglobulin.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11284525

Source DB:  PubMed          Journal:  South Med J        ISSN: 0038-4348            Impact factor:   0.954


  2 in total

1.  Toxic epidermal necrolysis - management issues and treatment options.

Authors:  Alan D Widgerow
Journal:  Int J Burns Trauma       Date:  2011-09-03

2.  Steven-Johnson syndrome due to unknown drugs [corrected].

Authors:  Raghu Prasada M Shivamurthy; Ravindra Kallappa; Shashikala G H Reddy; Druva Kumar B Rangappa
Journal:  Indian J Pharmacol       Date:  2012-01       Impact factor: 1.200

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.